Merrimack Pharmaceuticals is an integrated, biopharmaceutical company committed to the innovation of life-enhancing medicines for the treatment of autoimmune disease and cancer. Merrimack is privately held and located in Cambridge, Massachusetts.

Follow us on

LATEST NEWS
July 22, 2010 - Press Release Merrimack Pharmaceuticals and sanofi-aventis Initiate Enrollment in a Phase 2 Combination Study of MM-121 and exemestane in Breast Cancer June 17, 2010 - Press Release Melissa Kemp, Ph.D. Wins the Council for Systems Biology in Boston (CSB2) Award Sponsored by Merrimack Pharmaceuticals, Inc. June 3, 2010 - Press Release Merrimack Pharmaceuticals’ MM-111 Phase 1/2 Trial Design to be Presented at the 2010 ASCO Annual Meeting       Merrimack Pharmaceuticals, Inc on Facebook